Regor Therapeutics is Discovery Tools (Healthcare) in China that focus on developer business. Founded in 2018. They cover business area such as developer, biopharmaceutical technology, oncology, metabolic disease, autoimmune disease, development, innovative and clinically differentiate medicine, Computer, Rational Discovery) Platform, structural biology, computational chemistry, therapeutic biology, medicinal chemistry.
2018
( 6 years old in 2024 )
Developer
-
1206 Zhangjiang Rd, Building C
Pudong New District
Shanghai, 201210
China
Private
developerbiopharmaceutical technologyoncologymetabolic diseaseautoimmune diseasedevelopmentinnovative and clinically differentiate medicineComputerRational Discovery) Platformstructural biologycomputational chemistrytherapeutic biologymedicinal chemistry
* We use standard office opening hours in near Regor Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Regor Therapeutics is Discovery Tools (Healthcare) business from China that founded in 2018 (6 years old in 2024), Regor Therapeutics business is focusing on Developer.
Regor Therapeutics headquarter office and corporate office address is located in 1206 Zhangjiang Rd, Building C Pudong New District Shanghai, 201210 China.
Regor Therapeutics was founded in China.
In 2024, Regor Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Regor Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.